Cardiff Oncology Drops 34% After CEO and CFO Resign
Cardiff Oncology shares fall sharply as CEO and CFO step down amid leadership transition; interim CEO appointed to guide next phase of drug development.
Cardiff Oncology shares fall sharply as CEO and CFO step down amid leadership transition; interim CEO appointed to guide next phase of drug development.
Billionaire Daniel Loeb’s Third Point hedge fund plans to shake up CoStar Group by replacing board members and refocusing the company on its core business.
Pinterest plans to cut up to 15% of its workforce, shifting focus to AI products to boost revenue amid declining ad spending.
Intellia Therapeutics’ stock rises as the FDA clears a Phase 3 trial for its gene therapy, nexiguran ziclumeran, for a rare genetic disease.
Meta signs a multiyear $6 billion agreement with Corning to supply fiber-optic cables, expand U.S. AI data centers, and create skilled jobs in North Carolina.
Aerospace and defense giant RTX posts higher Q4 revenue and profit, boosted by F135 engine sales and commercial aircraft maintenance demand.